Invention Grant
![Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines](/docs/US/2023-04-18/US11629150B2/abs.jpg.600x600.jpg)
- Patent Title: Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines
-
Application No.: US17121392Application Date: 2020-12-14
-
Publication No.: US11629150B2Publication Date: 2023-04-18
- Inventor: Alexander Smith , Hannah S. White , Francis Xavier Tavares , Sergiy Krasutsky , Jian-Xie Chen , Roberta L. Dorrow , Hua Zhong
- Applicant: G1 Therapeutics, Inc.
- Applicant Address: US NC Research Triangle Park
- Assignee: G1 Therapeutics, Inc.
- Current Assignee: G1 Therapeutics, Inc.
- Current Assignee Address: US NC Research Triangle Park
- Agency: Knowles Intellectual Property Strategies, LLC
- Main IPC: C07D487/20
- IPC: C07D487/20 ; C07D487/14 ; C07D403/04 ; A61P35/00
![Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines](/abs-image/US/2023/04/18/US11629150B2/abs.jpg.150x150.jpg)
Abstract:
This invention is in the area of synthesizing pyrimidine-based compounds useful in the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.
Public/Granted literature
- US20210122755A1 SYNTHESIS OF N-(HETEROARYL)-PYRROLO[3,2-D]PYRIMIDIN-2-AMINES Public/Granted day:2021-04-29
Information query
